Changes in phosphoinositide metabolism were examined in washed rabbit platelets stimulated with 0.5/tM-ADP, 50,uM-adrenaline, or ADP and adrenaline in combination. Adrenaline does not stimulate platelet aggregation when used alone, but does potentiate aggregation stimulated by ADP. In platelets prelabelled with [32P]P1 and [3H]glycerol, adrenaline was found to potentiate the ADP-induced changes in platelet phospholipids, causing larger increases in the amount and labelling of phosphatidylinositol 4-phosphate (PIP) and phosphatidic acid than was observed with ADP alone. The combination of ADP and adrenaline did not produce a greater decrease in phosphatidylinositol 4,5-bisphosphate (PIP2) than was produced by ADP alone. In platelets prelabelled with [3H]inositol, adrenaline potentiated the increases in labelling of inositol phosphate and inositol bisphosphate stimulated by ADP; no increase in inositol trisphosphate labelling was detected with ADP alone or with the combination of ADP and adrenaline. Phentolamine, an a-adrenergic-receptor antagonist, blocked potentiation by adrenaline of ADP-induced changes in phosphoinositide metabolism. Propranolol and sotalol, ,6-adrenergic-receptor antagonists, augmented the potentiation; this is consistent with the concept that the effect of adrenaline is mediated by ,f-adrenergic receptors. The effect of adrenaline on phosphoinositide metabolism appears to be to potentiate the mechanisms by which ADP causes turnover of PIP and possibly degradation of PI, rather than the mechanism by which PIP2 is decreased.
INTRODUCTION
Adrenaline alone does not aggregate platelets, but increases their sensitivity to other agents such as ADP (O'Brien, 1964; Ardlie et al., 1966; Drummond, 1976; Hallam et al., 1981; Lalau Keraly et al., 1985) . Since a1-adrenergic receptors do not appear to be present on rabbit platelets (Grant & Scrutton, 1980) , this pro-aggregatory effect of adrenaline is apparently mediated in rabbit platelets by a2-adrenergic receptors (Hallam et al., 1981) . Stimulation of the az2-adrenergic receptor is thought to inhibit adenylate cyclase, possibly by a coupling through the guanine nucleotide binding protein GI (Homcy & Graham, 1985) . However, ADP itself blocks the stimulation of adenylate cyclase (Mills & Macfarlane, 1976) , and decreasing cyclic AMP in unstimulated platelets does not initiate aggregation (Haslam et al., 1978) . Thus it seems unlikely that the pro-aggregatory effect of adrenaline could be mediated by inhibition of adenylate cyclase.
Adrenaline also acts at the platelet ,-adrenergic receptor. According to Yu & Latour (1977) and Kerry et al. (1984) , the proportion of a-and fl-adrenergic receptors in the platelet determines whether the effect of adrenaline is pro-aggregatory or inhibitory. In rabbit platelets the proportion of a-to ,1-adrenergic receptors is 19:1 (Kerry et al., 1984) , and thus adrenaline has a pro-aggregatory effect.
ADP, which stimulates platelet aggregation without causing the secretion of platelet dense-granule contents, causes early changes in phosphoinositides; some of these changes may be due to elevation of cytosolic [Ca2+] (Lloyd et al., 1972 (Lloyd et al., , 1973a Leung et al., 1983; Vickers et al., 1982 Vickers et al., , 1986a . Turnover of PI has been found to be associated with stimulation of platelets by adrenaline (Deykin & Snyder, 1973; Wallace et al., 1982) , although the times of incubation were long, making it difficult to link the PI changes with aggregation. Grant & Scrutton (1980) have suggested that the effect of adrenaline may involve an increase in cytoplasmic Ca2 . If adrenaline causes increased influx of Ca2+, it could affect the action of phospholipase C on platelet phosphoinositides and this effect could be involved in the synergism with ADP. Alternatively, if adrenaline directly stimulates degradation of PIP2 by phospholipase C, the IP3 formed could mobilize Ca2+ from internal stores, and this may be involved in the synergism with ADP.
The present study was designed to investigate the changes in the phosphoinositides during stimulation of platelets with ADP and adrenaline alone and in combination. Since ADP does not induce the secretion of the contents of the dense granules in rabbit platelets (Ardlie et al., 1971) , and since secretion does not occur when rabbit platelets are aggregated by the combination of ADP and adrenaline (Lalau Keraly et al., 1985) , it is possible to study with rabbit platelets the changes in phosphoinositide metabolism involved in the synergism of platelet aggregation caused by ADP and adrenaline, without the complications of secondary stimulation of the platelets by secreted materials. (20, uCi/ml) as described previously (Vickers et al., 1982) . Platelets were finally suspended in Tyrode solution containing 0.35% albumin (Tyrode-albumin) and apyrase at a concentration capable of converting 0.25,tM-ATP into AMP in 120 s at 37 'C. The platelet count was adjusted to 109 platelets/ml.
MATERIALS AND METHODS
In experiments in which Li+ was used, 20 mM-Li+ was included in a Tyrode-albumin solution in which the amount of Na+ was decreased to maintain an osmolarity of 290 mosmol/l. After resuspension in the Li+-containing Tyrode-albumin solution, the platelets were incubated for 1 h at 37 'C; according to Imandt et al. (1977) , by 1 h the Li+ concentration in the platelets approaches 80% of the concentration in the medium.
To examine the secretion of dense-granule contents from platelets stimulated with ADP and adrenaline, the platelets were prepared as described above, except that they were labelled with 5-hydroxy[14C]tryptamine for 15 min at the end of the 1 h incubation in the first washing solution (Packham et al., 1977) . Secretion of 5-hydroxy[14C]tryptamine was determined by rapidly transferring the platelet sample from the aggregometer cuvette to a centrifuge tube 120 s after the addition of thrombin and centrifuging at 8000 g for 1.5 min; radioactivity was then determined in a sample of the supernatant fluid. ADP/adrenaline-induced stimulation of phospholipid metabolism in prelabelled platelets and determination of amounts and labelling of the phospholipids Platelets (1 ml) prelabelled with [32P]Pi and [3H]glycerol were stimulated with 0.5,uM-ADP and/or 50,/M-adrenaline. Aggregation was measured in a Payton Aggregation Module (Payton Associates, Scarborough, Ont., Canada). The reaction was terminated at specified times, and the lipids were extracted with a neutral solvent and with an acidic solvent and fractionated by t.l.c. as previously described (Vickers et al., 1982) . The amounts and labelling of the phospholipids were determined after scraping the spots containing them from the thin-layer plates by analysis of total Pi and scintillation counting respectively (Vickers et al., 1982 1984) , were stirred in a Payton Aggregation Module and stimulated with 0.5 /zM-ADP and/or 50,uM-adrenaline. The reaction was terminated at the specified times by addition of ice-cold trichloroacetic acid (final concn. 10%, w/v) with mixing. The inositol phosphates were recovered and fractionated as previously described (Vickers et al., 1984) .
The identities of the fractions eluted from the columns were confirmed by preparing a mixture of 32P-labelled 'P3 and IP2 from red-cell ghosts as described by Downes et al. (1982) and fractionating the mixture on the columns. Two well-separated peaks were obtained. The recovered peaks were then freed of salts and fractionated on cellulose thin-layer plates as described by Emilsson & Sundler (1984 The standardized values were then averaged and the significance of the data was assessed by using a paired t test.
RESULTS
Consistent with previous studies (Lalau Keraly et al., 1985) , adrenaline (0.1-50 /M) did not cause platelet shape change or aggregation, but potentiated aggregation induced by ADP in a concentration-dependent manner ( A relatively high concentration of adrenaline (50 gM) was used in these studies to facilitate the detection of any effects of the adrenaline alone, for comparison with the combined effects of ADP and adrenaline. Stimulation of platelets with a low concentration of ADP (0.5 /tM) tended to decrease the amount of PIP2 at 10 s (0.09 nmol/109 platelets), but the decrease was not significant. The labelling of PIP2 with [3H]glycerol or 32P was not significantly decreased at 10 s after stimulation with ADP. However, by 60 s the [3H]glycerol and 32P labelling was significantly decreased to 91 % (P < 0.05, n = 5) and 92% (P < 0.05, n = 5) respectively. Adrenaline alone had no significant effect on the amount or labelling with [3H]glycerol or 32P of PIP2 at 10 or 60 s. The combination of ADP and adrenaline had no significant effect on 32P labelling, but caused a significant decrease in the [3H]glycerol labelling of PIP2 at 10 s to 94.8% (P < 0.01,n = 6)andat60 sto91.8 % (P < 0.05,n = 6), although these changes were no greater than those caused by ADP alone. The specific radioactivity of PIP2 labelled with [3 H]glycerol was also decreased by the combination of ADP and adrenaline at both 10 and 60 s, to 95% and Platelets were prelabelled with 5-hydroxy[14C]tryptamine and stimulated in the absence of Li+, and the secreted 5-hydroxytryptamine in the medium (values in boxes) was determined after 2 min as described in the Materials and methods section. Table 1 . Amount, labelling and specific radioactivity of PIP in platelets prelabelied with 132P1p, and 13Hlglycerol and treated with Tyrode solution or 0.5 uM-ADP and 50 pM-adrenaline used alone or in combination
The platelets were prelabelled and stimulated and the phosphoinositides extracted and analysed as described in the Materials and methods section. Significance of the differences between platelets treated with Tyrode solution (control) and ADP and/or adrenaline (*P < 0.05, **P < 0.01) was assessed by a paired t test. At 60 s the combination of ADP and adrenaline caused significantly larger increases in the amount of PIP (P < 0.05), [32P]P, labelling (P < 0.01) and specific radioactivity (P < 0.05) and [3HJglycerol labelling (P < 0.01) than were caused by ADP alone. Results are means + S.E.M. (n = 6, except for ADP at 60 s, when n = 5).
[32P]P, Neither ADP nor adrenaline alone caused significant changes in the amount or labelling of PI. When ADP and adrenaline were used together, however, there was a tendency for the amount of PI to be decreased at 60 s to 93% ; this was not statistically different from the values obtained for controls. The labelling with [3H]glycerol was significantly decreased at 60 s to 91.6% (P < 0.01, n = 6); this decrease was significantly greater than that caused by ADP alone (P < 0.05, n = 6).
As previously described (Lloyd et al., 1972; Vickers et al., 1982) , ADP stimulation by itself did not increase the amount of PA, although the 32P and [3H]glycerol labelling of PA were significantly increased at 10 and 60 s (Table 2 ). In contrast, the combination of ADP and adrenaline significantly increased the amount of PA at 10 s. Adrenaline alone had little effect on the amount or labelling of PA (Table 2 ).
Vol. 242 (Fig. 2) . At the same time, adrenaline caused a significant increase only in the labelling of IP. When ADP and adrenaline were added together, larger increases in labelling of both 1P2 and IP were observed. Only for 1P2, however, was the increase in labelling in response to the combination of ADP and adrenaline significantly larger than that caused by ADP or adrenaline alone (Fig. 2) .
The effect of propranolol on the accumulation of the inositol phosphates caused by the combination of ADP and adrenaline is shown in Fig. 3 . The addition of propranolol (50 ,M), which had no effect alone, increased the labelling of both 1P2 and IP in response to the combination of ADP and adrenaline at 60 s. The increases in IP2 and IP produced by the combination of ADP and adrenaline in the presence of propranolol were significantly larger than those produced by the combination of ADP and adrenaline in the absence of propranolol. The effect of sotalol, another fl-adrenergicreceptor antagonist, was examined on the labelling of the inositol phosphates in response to low concentrations of ADP (0.2 /ZM) and adrenaline (0.6 pM), which had little effect alone but caused substantial increases in labelling of 'P2 and IP when added together. Sotalol (50 /M) had Li+ (20 mM) was present in all samples. Platelet preparation and statistical analysis of the data were done as described in the legend to Fig. 2 . Error bars indicate the range of the duplicate samples (n = 2): *P < 0.05, **P < 0.01. significant, P < 0.01, n = 6). With higher concentrations of ADP (0.5 tM) and adrenaline (50 uM), sotalol produced essentially the same effect at 60 s. Neither propranolol nor sotalol augmented changes in the inositol phosphates caused by the combination of ADP and adrenaline at 10 s. The a-adrenergic-receptor antagonist phentolamine completely blocked the increase in labelling of 1P2 and inhibited the increase in IP labelling by more than 50% in platelets stimulated with the combination of 0.5 /,M-ADP and 50 ,uM-adrenaline for 60 s (Fig. 4) .
DISCUSSION
Consistent with reports from other investigators (O'Brien, 1964; Ardlie et al., 1966; Drummond, 1976; Hallam et al., 1981; Lalau Keraly et al., 1985) , the present study demonstrates that adrenaline does not induce aggregation of rabbit platelets by itself, but potentiates their response to ADP. Associated with the potentiation of ADP-induced aggregation, adrenaline augmented some of the phosphoinositide changes stimulated by ADP. Although adrenaline alone did not cause large changes in the phosphoinositides and their degradation products, there were changes that may be significant in adrenaline potentiation of ADP-induced aggregation. Adrenaline (Leung et al., 1983; Vickers et al., 1986b ), the increased labelling could reflect increased turnover of these molecules. These data are compatible with an effect ofadrenaline on the interconversion of PI and PIP and degradation of PIP and PI by phospholipase C to DG, which can be phosphorylated to PA. In contrast with the action of ADP (Vickers et al., 1982 (Vickers et al., , 1986a Leung et al., 1983) , adrenaline did not cause detectable changes in PIP2.
With the low concentrations of ADP used in these experiments (0. 5 /SM), the changes in the phosphoinositides and inositol phosphates were similar to those seen in previous studies with 1O,M-ADP (Vickers et al., 1982 (Vickers et al., , 1986a Leung et al., 1983) . The small decrease in PIP2, compared with that caused by 10 ,tM-ADP used previously (Vickers et al., 1982 (Vickers et al., , 1986a , was consistent with the low concentration of ADP used, and the failure of the decrease to be significant may reflect the sensitivity of the assay methods. The low concentration of ADP caused increases in the amount, labelling and specific radioactivity of PIP. The increase in amount of PIP could be due to degradation of PIP2 or synthesis from PI. Since the decrease in amount of PIP2 was much smaller than the increase in amount of PIP, the major cause of the increase in PIP appears to have been increased synthesis of PIP from PI. Since the 32P specific radioactivity of ATP is higher than that of the phosphoinositides (Leung et al., 1983 , Vickers et al., 1986b PIP and PI by phospholipase C in ADP-stimulated platelets. In platelets prelabelled with [3H]glycerol, the specific radioactivity of the phosphoinositides is higher than that of PA (Vickers et al., 1986b) and thus synthesis of PA from DG formed by degradation of PIP or PI would account for the increased specific radioactivity of PA. Similarly, since the source of phosphate for synthesis of PA from DG is [32P]phosphate-labelled ATP, which has a higher specific radioactivity than PA (Vickers et al., 1986b) , the increase in PA specific radioactivity is also consistent with increased degradation of PIP and PI by phospholipase C and conversion of DG into PA. Thus activation of platelets with a low concentration of ADP results in degradation of PIP and possibly PI by phospholipase C, with the formation of IP, IP2 and PA, and a shift in the cycle of interconversion of PI and PIP toward increased synthesis of PIP from PI.
The potentiation of ADP-induced aggregation by adrenaline did not involve changes in PIP2 which were larger that those caused by ADP alone. In contrast, changes in PIP, PI, PA and IP2 in response to the combination of ADP and adrenaline were significantly greater than those caused by ADP alone. These results indicate that the effect of adrenaline was on the mechanism(s) by which ADP stimulates the increased synthesis of PIP from PI and degradation by phospholipase C of PIP and possibly PI. These changes are consistent with the effects of adrenaline alone.
A possible explanation of the potentiation by adrenaline of the ADP-induced changes is that the primary effect of ADP is on PIP2, with a secondary mobilization of Ca2+ which leads to phospholipase C degradation of PIP and PI. This hypothesis is supported by our observation that the Ca2+ ionophore A23187 increased the labelling with [3H]inositol of IP2 and IP, but not IP3, in aspirin-treated rabbit platelets (Vickers et al., 1985) , and the observation by Low et al. (1985) that the degradation of PIP by phospholipase C purified from platelets was more strongly stimulated by high concentrations of Ca2+ than was the degradation of PIP2. There is also evidence from studies using Ca2+ probes, including aequorin (Johnson et al., 1985) , quin2 (Rao et al., 1986) and fura2 (Rao et al., 1985) that adrenaline causes mobilization of intracellular Ca2+. Thus the effect of adrenaline may be to augment the ADP-induced mobilization of cytosolic Ca2 . In this case, the action of adrenaline on the phosphoinositides would be secondary to the mobilization of Ca2 . Since z2-adrenergic receptors apparently do not act directly on the pathways of phosphoinositide metabolism (Homcy & Graham, 1985) , the proposal that the effect of adrenaline on the phosphoinositides is secondary to Ca2+ changes is compatible with the conclusion that adrenaline stimulates a2-adrenergic receptors in rabbit platelets (Grant & Scrutton, 1980) . The possibility that Ca2+ mobilization is involved is also consistent with the augmentation of the ADP-and adrenaline-induced increase in IP2 and IP accumulation caused by propranolol and sotalol. It seems likely that propranolol and sotalol inhibit adrenaline-induced stimulation of cyclic AMP synthesis via a ,-adrenergic receptor, which would decrease the potential to sequester Ca2+ from the platelet cytoplasm (Kaser-Glanzmann et at., 1979) , making the Ca2+ mobilized by ADP and adrenaline more effective. The inhibition of the adrenaline potentiation of ADP-induced changes by phentolamine is consistent with adrenaline having its effect by an a2-adrenergic receptor.
Thus it appears that adrenaline, which by itself has little effect on phosphoinositide metabolism, exerts its effects on the mechanisms by which ADP causes increased synthesis of PIP from PI and degradation of PIP and possibly PI byphospholipase C; adrenaline does not appear to affect the mechanism by which ADP decreases PIP2.
